Published in J Virol on March 01, 1989
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J (1990) 3.31
Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A (1991) 2.87
Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc Natl Acad Sci U S A (1989) 2.65
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19
In vitro construction of poliovirus defective interfering particles. J Virol (1989) 2.10
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol (2000) 2.00
Genome-wide diversity and selective pressure in the human rhinovirus. Virol J (2007) 1.94
Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A (1990) 1.87
Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol (1999) 1.86
Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol (1992) 1.82
Conservation of RNA-protein interactions among picornaviruses. J Virol (1992) 1.81
Functional domains of the poliovirus receptor. Proc Natl Acad Sci U S A (1991) 1.77
Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees. J Virol (1998) 1.66
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol (1995) 1.63
Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J Virol (1998) 1.59
Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J Virol (1993) 1.54
Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol (2007) 1.54
Nucleotide sequences important for translation initiation of enterovirus RNA. J Virol (1991) 1.53
Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci U S A (1991) 1.52
High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol (1994) 1.52
Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol (1990) 1.45
Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence. J Virol (1994) 1.44
The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. J Virol (2006) 1.43
An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol (2007) 1.41
Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol (2002) 1.37
Impaired binding of standard initiation factors mediates poliovirus translation attenuation. J Virol (2003) 1.33
Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons. J Virol (2009) 1.32
An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol (1991) 1.31
A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence. J Virol (1992) 1.30
Attenuating mutations in the poliovirus 5' untranslated region alter its interaction with polypyrimidine tract-binding protein. J Virol (1997) 1.29
A search for structurally similar cellular internal ribosome entry sites. Nucleic Acids Res (2007) 1.29
Attenuation stem-loop lesions in the 5' noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J Virol (1996) 1.26
A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J Virol (1993) 1.25
Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol (2005) 1.22
Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells. J Virol (2005) 1.20
Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol (1997) 1.19
Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J Virol (1997) 1.15
Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J Virol (1995) 1.12
Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis. J Virol (2006) 1.11
A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats. J Virol (1999) 1.11
Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol (2004) 1.08
Cell-dependent role for the poliovirus 3' noncoding region in positive-strand RNA synthesis. J Virol (2004) 1.07
Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient. J Virol (2008) 1.06
Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol (2004) 1.02
Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity. Virology (2009) 1.01
Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J Clin Microbiol (2005) 1.00
Poliovirus tropism and attenuation are determined after internal ribosome entry. J Clin Invest (2004) 0.97
Epidemics to eradication: the modern history of poliomyelitis. Virol J (2007) 0.96
Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein. J Virol (1997) 0.95
An attenuating mutation in the 2A protease of swine vesicular disease virus, a picornavirus, regulates cap- and internal ribosome entry site-dependent protein synthesis. J Virol (2001) 0.93
A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J Virol (1995) 0.92
Molecular determinants for virulence in coxsackievirus B1 infection. J Virol (1997) 0.92
Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol (1995) 0.91
Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus. J Virol (1999) 0.90
Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. J Biomed Sci (2014) 0.88
Sequence analysis of the downstream 5' nontranslated region of seven echoviruses with different neurovirulence phenotypes. J Virol (1995) 0.87
A new internal ribosomal entry site 5' boundary is required for poliovirus translation initiation in a mouse system. J Virol (1998) 0.87
Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis. J Virol (2011) 0.86
Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J Virol (1996) 0.86
Evolution and Emergence of Enteroviruses through Intra- and Inter-species Recombination: Plasticity and Phenotypic Impact of Modular Genetic Exchanges in the 5' Untranslated Region. PLoS Pathog (2015) 0.86
Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. Front Microbiol (2012) 0.85
Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains. J Virol (2002) 0.83
A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell-type-specific block to viral replication. J Virol (2001) 0.83
Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3. Mol Genet Genomics (2006) 0.82
Neurovirulence of type 1 polioviruses isolated from sewage in Japan. Appl Environ Microbiol (2002) 0.81
Mechanisms controlling virulence thresholds of mixed viral populations. J Virol (2011) 0.81
Exchanges of genomic domains between poliovirus and other cocirculating species C enteroviruses reveal a high degree of plasticity. Sci Rep (2016) 0.75
Major alteration in coxsackievirus B3 genomic RNA structure distinguishes a virulent strain from an avirulent strain. Nucleic Acids Res (2014) 0.75
Molecular aspects of poliovirus pathogenesis. Proc Jpn Acad Ser B Phys Biol Sci (2007) 0.75
Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis. BMC Infect Dis (2016) 0.75
Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71. Virol J (2016) 0.75
Impaired binding of standard initiation factors eIF3b, eIF4G and eIF4B to domain V of the live-attenuated coxsackievirus B3 Sabin3-like IRES--alternatives for 5'UTR-related cardiovirulence mechanisms. Diagn Pathol (2013) 0.75
MicroRNA-134 regulates poliovirus replication by IRES targeting. Sci Rep (2017) 0.75
Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains. Eur J Clin Microbiol Infect Dis (2010) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell (1979) 12.83
Cloned poliovirus complementary DNA is infectious in mammalian cells. Science (1981) 12.50
Three-dimensional structure of poliovirus at 2.9 A resolution. Science (1985) 11.47
Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res (1984) 4.19
Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol (1986) 3.94
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol (1987) 2.36
In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26
Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol (1978) 1.96
An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology (1986) 1.61
A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol (1988) 1.58
Strategy for construction of live picornavirus vaccines. Vaccine (1988) 1.03
Poliovirus infection of established human blood cell lines: relationship between the differentiation stage and susceptibility of cell killing. Virology (1987) 1.02
Relation between genomic and capsid structures in RNA viruses. Nucleic Acids Res (1986) 0.94
Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature (1995) 10.89
Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14
Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09
Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1989) 5.98
The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61
Close evolutionary relationship between the chromosomally encoded beta-lactamase gene of Klebsiella pneumoniae and the TEM beta-lactamase gene mediated by R plasmids. FEBS Lett (1986) 5.13
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
Complete genomic sequence of the filamentous nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120. DNA Res (2001) 4.27
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. J Med Chem (1977) 4.19
Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med (2001) 4.19
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol (1986) 3.94
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A (1997) 3.88
Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology (1999) 3.83
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol (1999) 3.47
The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J (1990) 3.31
The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology (2001) 3.25
Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest (1998) 3.15
PC-904, a novel broad-spectrum semisynthetic penicillin with marked antipseudomonal activity: microbiological evaluation. Antimicrob Agents Chemother (1976) 2.91
Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A (1991) 2.87
Regulation of yAP-1 nuclear localization in response to oxidative stress. EMBO J (1997) 2.84
Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res (1994) 2.81
Isolation of Rickettsia tsutsugamushi antigenically different from Kato, Karp, and Gilliam strains from patients. Microbiol Immunol (1984) 2.70
Antibodies to type II collagen in relapsing polychondritis. N Engl J Med (1978) 2.65
Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol (1986) 2.63
Tumor angiogenesis in human lung adenocarcinoma. Cancer (1994) 2.59
Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55
Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet (2003) 2.52
Complete nucleotide sequence of the genome of coxsackievirus B1. Virology (1987) 2.49
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J (2005) 2.47
Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol (1999) 2.46
Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology (1996) 2.44
Bruxism physiology and pathology: an overview for clinicians. J Oral Rehabil (2008) 2.42
Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28
In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26
Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene (1993) 2.25
Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci U S A (1979) 2.25
Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19
Antigenic variation and resistance to neutralization in poliovirus type 1. Science (1985) 2.19
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14
In vitro construction of poliovirus defective interfering particles. J Virol (1989) 2.10
Statistical analysis of the 5' untranslated region of human mRNA using "Oligo-Capped" cDNA libraries. Genomics (2000) 2.09
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07
Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet (1995) 2.03
Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med (2001) 2.02
A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun (1995) 1.99
The genome of poliovirus is an exceptional eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol (1976) 1.99
Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol (1999) 1.96
Characterization of new hydrophobic pili of human enterotoxigenic Escherichia coli: a possible new colonization factor. Infect Immun (1984) 1.95
Immunohistochemical studies of extracellular matrix components and integrins in IgA nephropathy. Nephron (1994) 1.94
Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett (1999) 1.92
The native form and maturation process of hepatitis C virus core protein. J Virol (1998) 1.91
Further evaluation of the Biken test (modified Elek test) for detection of enterotoxigenic Escherichia coli producing heat-labile enterotoxin and application of the test to sampling of heat-stable enterotoxin. J Clin Microbiol (1982) 1.89
The genome-linked protein of picornaviruses. IV. Difference in the VPg's of encephalomyocarditis virus and poliovirus as evidence that the genome-linked proteins are virus-coded. Virology (1978) 1.89
Purification and characterization of Vibrio cholerae non-O1 heat-stable enterotoxin. Infect Immun (1986) 1.89
Defective interfering particles of poliovirus: mapping of the deletion and evidence that the deletions in the genomes of DI(1), (2) and (3) are located in the same region. J Mol Biol (1979) 1.87
Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev (1995) 1.86
Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol (1999) 1.86
Anomalous atlantoaxial portions of vertebral and posterior inferior cerebellar arteries. Neuroradiology (1985) 1.86
Distribution of archaea in a black smoker chimney structure. Appl Environ Microbiol (2001) 1.82
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82
Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol (1997) 1.81
Regulation of the yeast Yap1p nuclear export signal is mediated by redox signal-induced reversible disulfide bond formation. Mol Cell Biol (2001) 1.79
Transformation-defective mutants of Rous sarcoma virus with longer sizes of genome RNA and their highly frequent occurrences. J Virol (1979) 1.78
Expression of the O9 polysaccharide of Escherichia coli: sequencing of the E. coli O9 rfb gene cluster, characterization of mannosyl transferases, and evidence for an ATP-binding cassette transport system. J Bacteriol (1995) 1.78
Functional domains of the poliovirus receptor. Proc Natl Acad Sci U S A (1991) 1.77
Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med (1995) 1.77
In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity. Antimicrob Agents Chemother (1983) 1.77
The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.77
Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. J Gen Virol (1992) 1.76
Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett (1997) 1.74